All News #Library
Biotech
Recce Reports Positive Ph 2 Data For RECCE 327 In Bacterial Skin Infections
19 Feb 2025 //
GLOBENEWSWIRE
Recce Pharma Reports Positive Preclinical RECCE 327 Data In Lung Infection
13 May 2024 //
GLOBENEWSWIRE
Recce`s receives 2 patents in China for its RECCE 327, RECCE 529 anti-infectives
09 May 2024 //
PHARMABIZ
Recce Announces Committee Approves Infusion Rate in Ph I/II Trial of RECCE 327
25 Oct 2023 //
GLOBENEWSWIRE
Recce Announces Safety Committee Approves Next Dose of RECCE 327
29 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support